The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: Combined results of the North American and international trials

Journal of Clinical Psychiatry

Volumn 62, Issue 10, 2001, Pages 757-771

  Davis, J M ^a   Chen, N ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE MESILATE; BIPERIDEN; HALOPERIDOL; LORAZEPAM; OLANZAPINE; PLACEBO; RISPERIDONE;

ADULT; AGED; AKATHISIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERIVATIZATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; FACTORIAL ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTICENTER STUDY; NEGATIVE SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA;

EID: 0035191690     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n1003     Document Type: Article

References (28)

1. "New" rather than "atypical"
2. Olanzapine on trial
3. Risperidone: How good is the evidence for efficacy?
4. Atypical antipsychotics in the treatment of schizophrenia: A systematic overview and meta-regression analysis
5. A new algorithm for treating schizophrenia
6. The Texas Medication Algorithms Project (TMAP) schizophrenia algorithms
7. Consultant for the pharmacotherapy of schizophrenia
8. Expert consensus guideline series: Treatment of schizophrenia 1999
9. The practice guidelines for the treatment of patients with schizophrenia
10. Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations
11. Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
12. Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial
13. Olanzapine versus haloperidol: Acute phase results of the international double-blind olanzapine trial
14. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
15. Atypical antipsychotics: Are some more atypical than others?
16. Antipsychotics: Past and future
17. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American Trials
18. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
19. Evidence of clozapine's effectiveness in schizophrenia: A systematic review and meta-analysis of randomized trials
20. The brief psychiatric rating scale
21. Anchoring the BPRS: An aid to improved reliability
22. A rating scale for extrapyramidal side effects
23. A rating scale for drug-induced akathisia
24. Clinical correlates of akathisia in acute psychiatric inpatients
25. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia
26. Negative symptoms: A path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine